Pds biotech to participate at the a.g.p. virtual annual healthcare company showcase

Princeton, n.j., may 20, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that frank bedu-addo, phd, president and chief executive officer of pds biotech will participate in a fireside chat during the alliance global partners (“a.g.p.”) virtual annual healthcare company showcase, taking place may 21, 2025.
PDS Ratings Summary
PDS Quant Ranking